MicroTransponder has gone through the long process of translating a neuroscience breakthrough from UT Dallas into a therapy that enables stroke victims to regain upper limb movement. We have completed a 20 patient trial in the UK, a 17 patient trial in the U.S. and are scheduled to start a 120 patient trial in August at sites such as the Mayo Clinic, Cornell, Emory, and Vanderbilt. We have 22 issued U.S. patents as well.